Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2017: 3.556

CiteScore 2017: 2.34

SCImago Journal Rank (SJR) 2017: 1.114
Source Normalized Impact per Paper (SNIP) 2017: 1.188

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 38, Issue 11

Issues

Transforming Growth Factor-β1 as a Surrogate Marker of Hepatic Dysfunction in Chronic Liver Diseases

Robert Flisiak / Danuta Prokopowicz
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2000.170

Abstract

The aim of the study was to evaluate the possible association between plasma concentrations of transforming growth factor-β1 (TGF-β1) and the degree of hepatic dysfunction in patients with chronic liver diseases. TGF-β1 was measured with an enzyme immunoassay in plasma from 21 patients with chronic active hepatitis and 40 patients with liver cirrhosis. Normal values were obtained from a group of 13 healthy volunteers. Results were analysed with respect to aetiology and the degree of liver insufficiency as evaluated by the Child-Pugh classification. The mean plasma concentration of TGF-β1in patients 36.9±2.8 ng/ml) was twice that found in normal volunteers (18.3±1.6 ng/ml). The highest values were observed in patients with alcoholic liver cirrhosis (44.4±4.7 ng/ml). Plasma TGF-β1 showed a statistically significant positive correlation with the degree of liver insufficiency. These results indicate the possible use of plasma TGF-β1 measurement as a good marker of liver function impairment. Further observation of patients involved in this study may help to evaluate its possible prognostic value in chronic liver diseases.

About the article

Published Online: 2005-06-01

Published in Print: 2000-11-12


Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 38, Issue 11, Pages 1129–1131, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2000.170.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Haristi Gaitantzi, Christoph Meyer, Pia Rakoczy, Maria Thomas, Kristin Wahl, Franziska Wandrer, Heike Bantel, Hamed Alborzinia, Stefan Wölfl, Sabrina Ehnert, Andreas Nüssler, Ina Bergheim, Loredana Ciuclan, Matthias Ebert, Katja Breitkopf-Heinlein, and Steven Dooley
Cell Death & Disease, 2018, Volume 9, Number 2
[3]
Mei-Na Shi
World Journal of Gastroenterology, 2006, Volume 12, Number 15, Page 2357
[4]
Paula C. Arriola Benitez, Romina Scian, Diego J. Comerci, Diego Rey Serantes, Silvia Vanzulli, Carlos A. Fossati, Guillermo H. Giambartolomei, and M. Victoria Delpino
The American Journal of Pathology, 2013, Volume 183, Number 6, Page 1918
[5]
O.A. Gressner, R. Weiskirchen, and A.M. Gressner
Journal of Cellular and Molecular Medicine, 2007, Volume 11, Number 5, Page 1031
[6]
Nam P. Nguyen, John E. Antoine, Suresh Dutta, Ulf Karlsson, and Sabah Sallah
Cancer, 2002, Volume 95, Number 5, Page 1151

Comments (0)

Please log in or register to comment.
Log in